ARTV
Artiva Biotherapeutics
ARTV
ARTV
57 hedge funds and large institutions have $213M invested in Artiva Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
33% less capital invested
Capital invested by funds: $319M → $213M (-$106M)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.1M | |
| 2 | +$788K | |
| 3 | +$290K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$271K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$261K |
Top Sellers
| 1 | -$70.6K | |
| 2 | -$40.2K | |
| 3 | -$26.9K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$19.7K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.5K |